- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Niet van toepassing
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Reactions at the injection site: pain (52.6%), swelling/edema/induration (16.5%), and erythema (14.4%).
The most frequently reported systemic reactions were myalgia (14.6%) and headache (13.5%).
[SmPC Typhim]
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Safety and effectiveness in children under 2 years of age have not been established. Vaccination before the age of two is not recommended, as typhoid fever is rare in infants. In addition, the antibody titer after vaccination may be lower in this age group.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Cholera vaccines | ||
|---|---|---|
| J07AE01 | ||
| Haemophilus influenzae B vaccines | ||
|---|---|---|
| J07AG01 | ||
| Meningococcal vaccines | ||
|---|---|---|
| J07AH09 | ||
| J07AH07 | ||
| J07AH08 | ||
| J07AH | ||
| Pertussis vaccines | ||
|---|---|---|
| J07AJ52 | ||
| Pneumococcal vaccines | ||
|---|---|---|
| J07AL02 | ||
| Tuberculosis vaccines | ||
|---|---|---|
| J07AN01 | ||
| Typhoid vaccines | ||
|---|---|---|
| J07AP01 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Emergent Netherlands B.V, SmPC Vivotif (RVG 120941) 29-01-2019, www.geneesmiddeleninformatiebank.nl
- Sanofi Pasteur Europe, SmPC Typhim (RVG 17568) 05-12-2019, www.geneesmiddeleninformatiebank.nl
- Sanofi Winthrop Industrie, SmPC Typhim (RVG 17568) 27-11-2024, www.geneesmiddeleninformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
